Taoka Chemical Co., Ltd. (4113) AI Stock Analysis

• Market Cap: ¥17.54B
• Dividend Yield: 3.59%
• Average Volume (3M): 35.67K
• Price to Earnings (P/E): 11.9
• Beta (1Y): 0.86
• Revenue Growth: 4.85%
• EPS Growth: 80.14%
• Country: JP
• Employees: 458
• Sector: Basic Materials
• Sector Strength: 71
• Industry: Chemicals - Specialty
• EPS (TTM): 27.36
• Shares Outstanding: 14,440,000
• 10 Day Avg. Volume: 32,090
• 30 Day Avg. Volume: 35,673
• PEG Ratio: -0.44
• Price to Book (P/B): 0.70
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -4.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 79 Outperform
• Price Target: ¥1,332.00 ▲(8.82%Upside)

Taoka Chemical Co., Ltd. receives a high overall stock score driven by its robust financial performance, positive technical indicators, and attractive valuation. The company's strong cash flow and low leverage provide a solid foundation for future growth. The technical analysis indicates strong market momentum, while the low P/E ratio and reasonable dividend yield enhance its investment attractiveness.

Taoka Chemical Co., Ltd. Business Overview & Revenue Model

Company Description

Taoka Chemical Co., Ltd. is a Japanese company that specializes in the production and sale of fine chemical products. The company operates in various sectors including pharmaceuticals, agrochemicals, and specialty chemicals. Its core products include functional chemicals, intermediates, and additives, which are utilized in a wide range of industrial applications.

How the Company Makes Money

Taoka Chemical Co., Ltd. generates revenue primarily through the manufacture and sale of its chemical products. The company supplies fine chemicals and intermediates to businesses in the pharmaceutical and agrochemical industries, where these products are used in the production of drugs and agricultural products. Additionally, Taoka Chemical offers specialty chemicals for various industrial applications, contributing to its earnings. The company's revenue model is supported by its ability to produce high-quality, innovative chemical solutions that meet the specific needs of its clients. Strategic partnerships and collaborations with other companies in the chemical and related industries also play a role in enhancing its market reach and profitability.

Taoka Chemical Co., Ltd. Financial Statement Overview

Summary

Taoka Chemical Co., Ltd. shows a strong financial position with solid revenue and profit growth, effective cost management, and efficient use of equity. The company maintains a healthy balance sheet with low leverage and robust cash flow, supporting its ability to invest in future growth opportunities. However, attention should be paid to the slight decrease in the equity ratio.

Income Statement

The company's revenue growth has been positive, with a notable increase from the previous year. Gross profit margin is stable, indicating efficient production and cost management. Net profit margin has improved significantly, reflecting enhanced profitability. EBIT and EBITDA margins show strong operational performance, contributing to a solid income statement.

Balance Sheet

The balance sheet shows a strong equity position with a healthy debt-to-equity ratio, suggesting low leverage risks. The return on equity indicates efficient use of equity capital to generate profits. However, the equity ratio decreased slightly, indicating a minor shift in asset financing structure.

Cash Flow

The cash flow statement is robust, with strong operating cash flow and positive free cash flow growth. The operating cash flow to net income ratio suggests effective cash generation from operations. Free cash flow has been consistently positive, indicating good cash management and potential for reinvestment and growth.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	29.69B	29.93B	28.54B	30.17B	32.37B	32.06B
Gross Profit	4.87B	5.49B	4.58B	4.00B	6.32B	7.22B
EBITDA	3.05B	3.46B	2.60B	1.95B	4.25B	5.16B
Net Income	1.04B	1.48B	820.48M	310.65M	2.06B	2.62B
Balance Sheet
Total Assets	29.67B	30.41B	29.72B	31.07B	32.42B	27.96B
Cash, Cash Equivalents and Short-Term Investments	1.12B	1.18B	972.01M	853.40M	718.63M	830.35M
Total Debt	1.65B	1.49B	2.21B	4.33B	808.15M	555.36M
Total Liabilities	11.65B	11.91B	12.51B	14.50B	15.67B	12.72B
Stockholders Equity	18.02B	18.50B	17.21B	16.57B	16.75B	15.24B
Cash Flow
Free Cash Flow	0.00	2.97B	2.49B	-2.85B	-3.41B	3.16B
Operating Cash Flow	0.00	4.37B	3.63B	1.48B	-1.33B	5.22B
Investing Cash Flow	0.00	-1.42B	-1.14B	-4.34B	-2.08B	-2.09B
Financing Cash Flow	0.00	-997.00M	-2.39B	3.00B	-273.53M	-680.45M

Taoka Chemical Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1224.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4113, the sentiment is Positive. The current price of 1224 is below the 20-day moving average (MA) of 1226.40, above the 50-day MA of 1183.90, and above the 200-day MA of 1041.71, indicating a neutral trend. The MACD of 10.27 indicates Positive momentum. The RSI at 51.47 is Neutral, neither overbought nor oversold. The STOCH value of 44.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4113.

Taoka Chemical Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4113	79 Outperform	¥17.54B	11.87		3.59%	4.85%	80.14%
4229	79 Outperform	¥18.87B	9.83		3.51%	0.78%	-5.93%
4064	76 Outperform	¥17.65B	7.90		4.27%	12.71%	123.52%
4409	74 Outperform	¥17.32B	11.07		2.46%	5.96%	182.60%
4092	73 Outperform	¥17.89B	6.99		4.53%	0.79%	60.97%
4973	72 Outperform	¥17.29B	11.27		4.08%	10.43%	187.34%
Sector *	44 Neutral	C$982.42M	-6.71	-13.24%	2.54%	17.20%	-32.72%

Taoka Chemical Co., Ltd. Corporate Events

Taoka Chemical Increases Year-End Dividend Amid Strong Financial Results

Taoka Chemical Co., Ltd. announced an increase in its year-end dividend per share from the forecasted ¥18.00 to ¥22.00, based on strong financial results for the fiscal year ended March 31, 2025. This decision reflects the company’s robust financial performance and commitment to returning value to shareholders, with the total dividends amounting to ¥315 million, sourced from retained earnings.

Taoka Chemical Co., Ltd. Reports Strong Financial Recovery in FY2025

Taoka Chemical Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with notable increases in net sales and profits. The company achieved a 4.9% increase in net sales and substantial growth in operating and ordinary profits, indicating a strong recovery from the previous year’s decline. This financial upswing reflects positively on the company’s operational efficiency and market positioning, potentially enhancing stakeholder confidence.

Taoka Chemical Reports Strong Financial Recovery in FY 2025

Taoka Chemical Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ending March 2025. The company achieved a 4.9% increase in net sales and a substantial rise in operating profit by 75.6%, indicating a strong recovery from the previous year’s decline. This growth reflects positively on the company’s operational efficiency and market positioning, potentially benefiting stakeholders through increased profitability and shareholder value.